| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/0008-5472.CAN-13-2037 |
| P698 | PubMed publication ID | 25381153 |
| P50 | author | Giovanni Esposito | Q96066692 |
| Stefan Walenta | Q107365083 | ||
| Wolfgang Müller-Klieser | Q110244170 | ||
| Andrea Rasola | Q37379515 | ||
| Stefano Indraccolo | Q39186456 | ||
| Luca Persano | Q43121424 | ||
| Elisabetta Rossi | Q55271242 | ||
| Francesco Ciccarese | Q56836102 | ||
| Silvia Valtorta | Q58349173 | ||
| Elisabetta Zulato | Q58885133 | ||
| Matteo Curtarello | Q58952208 | ||
| P2093 | author name string | Mario Plebani | |
| Alberto Amadori | |||
| Giorgia Nardo | |||
| Rosa Maria Moresco | |||
| Roberta Bertorelle | |||
| Sergio Todde | |||
| Anna Pastò | |||
| Giulia Guzzo | |||
| Aichi Msaki | |||
| Henrike Schroer | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | phenotype | Q104053 |
| P304 | page(s) | 120-133 | |
| P577 | publication date | 2014-11-07 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | VEGF-targeted therapy stably modulates the glycolytic phenotype of tumor cells | |
| P478 | volume | 75 |
| Q37362844 | A hypoxic signature marks tumors formed by disseminated tumor cells in the BALB-neuT mammary cancer model |
| Q89509558 | Anti-Angiogenic Effects of Phytochemicals on miRNA Regulating Breast Cancer Progression |
| Q90608594 | Concurrent imaging of vascularization and metabolism in a mouse model of paraganglioma under anti-angiogenic treatment |
| Q37588402 | Divergent in vitro/in vivo responses to drug treatments of highly aggressive NIH-Ras cancer cells: a PET imaging and metabolomics-mass-spectrometry study. |
| Q37588253 | Etoposide-Bevacizumab a new strategy against human melanoma cells expressing stem-like traits |
| Q64251353 | LKB1 and Tumor Metabolism: The Interplay of Immune and Angiogenic Microenvironment in Lung Cancer |
| Q55209479 | Mathematical Modeling of the Function of Warburg Effect in Tumor Microenvironment. |
| Q58705769 | Metabolic Plasticity of Tumor Cell Mitochondria |
| Q47114557 | Metabolic alterations underlying Bevacizumab therapy in glioblastoma cells. |
| Q39456875 | Nutrient Exploitation within the Tumor-Stroma Metabolic Crosstalk |
| Q91826329 | Oncogenic pathways and the electron transport chain: a dangeROS liaison |
| Q93148158 | Overcoming platinum-acquired resistance in ovarian cancer patient-derived xenografts |
| Q26766351 | Potential of Induced Metabolic Bioluminescence Imaging to Uncover Metabolic Effects of Antiangiogenic Therapy in Tumors |
| Q90731806 | Prospect of immunotherapy combined with anti-angiogenic agents in patients with advanced non-small cell lung cancer |
| Q40978947 | Recruitment of CD11b+Ly6C+ monocytes in non-small cell lung cancer xenografts challenged by anti-VEGF antibody |
| Q58734114 | Rescue of 2-Deoxyglucose Side Effects by Ketogenic Diet |
| Q91963226 | Rewiring of Lipid Metabolism and Storage in Ovarian Cancer Cells after Anti-VEGF Therapy |
| Q36559687 | Sigma-2 Receptors Play a Role in Cellular Metabolism: Stimulation of Glycolytic Hallmarks by CM764 in Human SK-N-SH Neuroblastoma |
| Q59126976 | Statin-induced metabolic reprogramming in head and neck cancer: a biomarker for targeting monocarboxylate transporters |
| Q47948966 | Suppression of oxidative phosphorylation confers resistance against bevacizumab in experimental glioma |
| Q36910309 | Targeting Metabolic Symbiosis to Overcome Resistance to Anti-angiogenic Therapy |
| Q44456046 | The Challenges of Modeling Drug Resistance to Antiangiogenic Therapy |
| Q39232954 | Trimming the Vascular Tree in Tumors: Metabolic and Immune Adaptations |
| Q42236394 | Vascular endothelial growth factor blockade elicits a stable metabolic shift in tumor cells: therapeutic implications |
| Q55286904 | [18F]FDG and [18F]FLT PET for the evaluation of response to neo-adjuvant chemotherapy in a model of triple negative breast cancer. |
Search more.